|
|
Sirtex Medical Limited - Comparative Business Analysis Snapshot
Business Description
Sirtex Medical Limited. The Group's principal activities are manufacturing, distributing and conducting research and development leading to commercialisation of liver cancer treatments using novel small particle technology. Its main product is SIR-Spheres. Operations are carried out in Asia Pacific, North America and Europe.
Competitor Analysis
This analysis compares Sirtex Medical Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
